Late-breaking AMETHYST Part A study results to be presented, showing safety and efficacy of litifilimab in cutaneous lupus erythematosus (CLE) Litifilimab was recently granted Bre ...
Datavant, the data collaboration platform trusted for healthcare, today announced that it will showcase its 2026 Best in KLAS Risk Adjustment Coding, Retrieval & Compliance Soluti ...